On Dec 7, the "2025 High-Quality Development Conference for Innovative Drugs," guided by the National Healthcare Security Administration and jointly hosted by the Guangzhou Municipal People's Government and the Guangdong Provincial Medical Insurance Bureau, was held in Guangzhou. The conference was organized by four departments including the Guangzhou Municipal Medical Insurance Bureau.

At the conference, the National Healthcare Security Administration and the Ministry of Human Resources and Social Security released the *National Drug List for Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance (2025)*, which includes 114 new drugs. Check if any of your commonly used medications are listed below.

Aclidinium Bromide Inhalation Powder
Allisartan Isoproxil and Indapamide Sustained-Release Tablets
Ivosidenib Tablets
Ipilolimab and Toripalimab Injection
Isatuximab Injection
Enricafusp Alfa Injection
Amisulpride Orally Disintegrating Tablets
Angoriximab Injection
Onradivir Tablets
Olanzapine and Fluoxetine Capsules
Orelizumab Injection
Benralizumab Injection
Perampanel Oral Suspension
Pyrotinib Maleate Tablets
Brolucizumab Injection
Shenyu Ningshen Tablets
Estradiol and Dydrogesterone Tablets
Abiraterone Acetate Tablets (II)
Fludrocortisone Acetate Tablets
Megestrol Acetate Oral Suspension
Lefamulin Acetate Tablets
Lefamulin Acetate Injection Concentrate
Deuterated Enzalutamide Soft Capsules
Technetium [99mTc] Tetrofosmin Injection
Dotinelor Tablets
Entrectinib and Propofol Tablets
Entinostat Tablets
Fenebrutinib Injection
Fonazineumab Injection
Furosemide Oral Solution
Fluzorexant Tablets
Compound Binavuxi Granules
Gefitolimab Injection
Gesoriximab Tablets and Citric Acid Fovistinib Capsules
Citric Acid Golerixant Tablets
Guselkumab Injection (Intravenous Infusion)
Hexadienoic Acid Taletrectinib Capsules
Pritelivir Mesylate Tablets
Jinpei Somatropin Injection
Capivasertib Tablets
Lisitinib Tablets
Risankizumab Injection
Risankizumab Injection (Subcutaneous)
Fosphenytoin Sodium Injection Concentrate
Sulfometuron Methyl Imatinib Tablets
Luvomecitinib Tablets
Acalabrutinib Maleate Tablets
Masuparvatoxel Tablets
Niraparib and Abiraterone Tablets
Peramivir Injection
Penpulimab Injection and Pitobrutinib Tablets
Capsaicin Famitinib Capsules and Calcium Gluconate Sodium Chloride Injection
Pratinib and Citric Acid Tetomotide Tablets
Qifang Bitong Tablets
Oxycodone and Nalmefene Sustained-Release Tablets
Deferiprone Tablets
Perfluorohexyloctane Eye Drops
Retagliptin and Metformin Tablets (1)
Retagliptin and Metformin Tablets (II)
Senaparib Capsules
Sepotinib Capsules
Sarilumab Injection
Sacubitril and Allisartan Calcium Tablets
Sumatriptan and Naproxen Sodium Tablets
Spesolimab Injection
Stamulumab Injection
Tagogumab Injection
Tirzepatide Injection
Tepotinib and Nivolumab Injection
Wenyang Jiedu Granules
Linaclotide Glutarate Capsules
Cetuximab and Nivolumab Injection
Ursodeoxycholic Acid Oral Suspension
Guanfacine Hydrochloride Sustained-Release Tablets
Gicartinib Hydrochloride Tablets
Labetalol Hydrochloride and Sodium Chloride Injection
Lerociclib Hydrochloride Tablets
Tenapanor Hydrochloride Tablets
Vancomycin Hydrochloride Capsules
Irinotecan Hydrochloride Liposome Injection
Irinotecan Hydrochloride Liposome Injection (II)
Dexmethylphenidate Hydrochloride Sustained-Release Capsules
Zolinitinib Hydrochloride Tablets
Yangxue Qufeng Zhitong Granules
Inalisib Tablets
Inotuzumab Injection
Evocalcet Tablets
Evolocumab Injection
Esperaglutide Alpha Injection
Yipei Somatropin Injection
Yiqi Qingfei Granules
Inclisiran Sodium Injection
Fish Oil (3% 6) Olive Oil Medium/Long-Chain Fat Emulsion/Amino Acids (16)/Glucose (13%) Injection
Yunv Jian Granules
Recombinant Human Granulocyte Colony-Stimulating Factor Alpha for Injection
Aripiprazole Microspheres for Injection
Aztreonam and Avibactam Sodium for Injection
Fosaprepitant and Palonosetron for Injection
Lusutrombopag and Sutimlimab for Injection
Meropenem and Sodium Chloride Injection
Petorohemagglutinin Alpha for Injection
Recaticimab for Injection
Rekamtuzumab for Injection
Suvecaltamab for Injection
Tenecteplase for Injection
Imipenem, Cilastatin Sodium, and Sodium Chloride Injection
Cefepime Hydrochloride and Sodium Chloride Injection
Recombinant Human Coagulation Factor Va NO1 for Injection
Paclitaxel Oral Solution
Paliperidone Palmitate Injection (II)

China's First "Commercial Health Insurance Innovative Drug List" Released

These Drugs Are Included

On the same day, China's first Commercial Health Insurance Innovative Drug List was released at the conference. The list focuses on drugs with significant clinical value, high innovation, and clear patient benefits that fall outside the coverage scope of basic medical insurance.

Through processes including voluntary application, expert review, review by commercial insurance experts, calculation, and price negotiations, 19 drugs from 18 innovative pharmaceutical companies were successfully included. These cover therapeutic areas such as oncology, rare diseases, and chronic diseases, including nine Category 1 innovative drugs.

The Commercial Health Insurance Innovative Drug List highlights three key features: First, it reflects a commitment to supporting innovation, as the included drugs represent recent advancements in medical technology, covering热门靶点药物 like CAR-T, TCE therapies, and bispecific antibodies. Second, it addresses key focus areas, including drugs for conditions like Alzheimer's disease that align with population aging trends, as well as treatments for rare diseases more common in children, such as Gaucher disease and neuroblastoma. Third, it clarifies the coverage boundaries between basic medical insurance and commercial insurance. Basic insurance adheres to the principle of "covering the basics," focusing on drugs that are safe, reliable, effective, and have well-established targets and mechanisms, while commercial insurance places greater emphasis on innovative and cutting-edge medications.

Let’s take a look at which innovative drugs are included:

19 Drugs Successfully Included in the 2025 "Commercial Health Insurance Innovative Drug List"
Ipilimumab Injection
Toluene Sulfonamide Injection
Tazemetostat Hydrobromide Tablets
Lurbinectedin for Injection
Naxitamab Injection
Sapropterin Dihydrochloride Tablets
Lecanemab Injection
Donanemab Injection
Dinutuximab Beta Injection
Zenidatamab for Injection
Teduglutide for Injection
Relmacabtagene Autoleucel Injection
Idecabtagene Vicleucel Injection
Zevorcabtagene Autoleucel Injection
Naxicabtagene Autoleucel Injection
Enapotamab Injection
Axicabtagene Ciloleucel Injection
Taquitumab Injection
Velaglucerase Alfa for Injection

Source: Guangzhou Daily